- $4.1 BnWorld market, 2023
- $5.9 BnProjected, 2033
- 3.8%Growth a year (CAGR)
- 393Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$1.7 Bn
1.8% a year · 42% of the world -
2
China
$326 Mn
5.3% a year · 8% of the world -
3
Canada
$325 Mn
3.8% a year · 8% of the world -
4
Japan
$252 Mn
4.3% a year · 6.2% of the world -
5
Germany
$149 Mn
2% a year · 3.7% of the world -
6
France
$112 Mn
2.8% a year · 2.7% of the world -
7
UK
$106 Mn
1.8% a year · 2.6% of the world -
8
Brazil
$102 Mn
4.8% a year · 2.5% of the world -
9
Italy
$97 Mn
3.3% a year · 2.4% of the world -
10
Ecuador
$81 Mn
4.4% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
SpainAngioplasty Balloons by country and region
India
Saudi Arabia
Mexico
Australia
South Africa
UAE
Egypt
Philippines
Hong Kong
Malaysia
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 4,003 papers since 2021
- Balloon angioplasty for acute posterior communicating artery occlusion due to dissection: illustrative case. Journal of neurosurgery. Case lessons, 2026
- Achieved LDL-C Levels and Clinical Outcomes Following Percutaneous Coronary Intervention with Drug-Coated Balloons for De Novo Coronary Lesions. Journal of atherosclerosis and thrombosis, 2026
- Patient-Specific Physical and Computational Models for Replicating Coronary Stent Deployment. JACC. Case reports, 2026
- A Race Against Time: Contralateral Acute Limb Ischemia During Catheter-Directed Thrombolysis for Peripheral In-Stent Thrombosis-A Case Report. Case reports in cardiology, 2026
- Low-Dose Drug-Coated Balloon Treatment Effectively Maintains 1-Year Clinical Patency in Korean Patients With Femoropopliteal Artery Lesions: There Is Still Room for Improvement. Korean circulation journal, 2026
Compare Angioplasty Balloons side by side
Key companies in Angioplasty Balloons
Boston Scientific Corporation
Medtronic PLC
B. Braun Melsungen AG
Biotronik SE & Co. KG
Terumo Corporation
Quick answers
How big is the Angioplasty Balloons market?
The world Angioplasty Balloons market was worth about $4.1 Bn in 2023 and is projected to reach $5.9 Bn by 2033, growing 3.8% a year (CAGR).
Which country has the largest Angioplasty Balloons market?
The US is the largest of the 24 countries we cover, at $1.7 Bn in 2023. India grows fastest, at 6.8% a year.
How many clinical trials are running in Angioplasty Balloons?
ClinicalTrials.gov lists 393 active trials worldwide (recruiting, about to start or running), most of them in China, as of 10 Nov 2026.
How much research is published on Angioplasty Balloons?
PubMed lists about 4,003 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.